Melatonergic signalling instructs transcriptional inhibition of IFNGR2 to lessen interleukin-1β-dependent inflammation.
Yaoyao XiaQingzhuo ZhangYuyi YeXiaoyan WuFang HeYuanyi PengYulong YinWenkai RenPublished in: Clinical and translational medicine (2022)
Our conceptual framework provides potential therapeutic targets to prevent and/or treat inflammatory diseases associating with excessive IL-1β production.